Literature DB >> 18818306

Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Pablo A González1, Carolina E Prado, Eduardo D Leiva, Leandro J Carreño, Susan M Bueno, Claudia A Riedel, Alexis M Kalergis.   

Abstract

Respiratory syncytial virus (RSV) infection is one of the leading causes of infant hospitalization and a major health and economic burden worldwide. Infection with this virus induces an exacerbated innate proinflammatory immune response characterized by abundant immune cell infiltration into the airways and lung tissue damage. RSV also impairs the induction of an adequate adaptive T cell immune response, which favors virus pathogenesis. Unfortunately, to date there are no efficient vaccines against this virus. Recent in vitro and in vivo studies suggest that RSV infection can prevent T cell activation, a phenomenon attributed in part to cytokines and chemokines secreted by RSV-infected cells. Efficient immunity against viruses is promoted by dendritic cells (DCs), professional antigen-presenting cells, that prime antigen-specific helper and cytotoxic T cells. Therefore, it would be to the advantage of RSV to impair DC function and prevent the induction of T cell immunity. Here, we show that, although RSV infection induces maturation of murine DCs, these cells are rendered unable to activate antigen-specific T cells. Inhibition of T cell activation by RSV was observed independently of the type of TCR ligand on the DC surface and applied to cognate-, allo-, and superantigen stimulation. As a result of exposure to RSV-infected DCs, T cells became unresponsive to subsequent TCR engagement. RSV-mediated impairment in T cell activation required DC-T cell contact and involved inhibition of immunological synapse assembly among these cells. Our data suggest that impairment of immunological synapse could contribute to RSV pathogenesis by evading adaptive immunity and reducing T cell-mediated virus clearance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818306      PMCID: PMC2567482          DOI: 10.1073/pnas.0802555105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 2.  Antigen presentation to naive CD4 T cells in the lymph node.

Authors:  Andrea A Itano; Marc K Jenkins
Journal:  Nat Immunol       Date:  2003-08       Impact factor: 25.606

3.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

4.  Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells.

Authors:  H Bartz; O Türkel; S Hoffjan; T Rothoeft; A Gonschorek; U Schauer
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

5.  Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus.

Authors:  Yuki Kondo; Hiroto Matsuse; Ikuko Machida; Tetsuya Kawano; Sachiko Saeki; Shinya Tomari; Yasushi Obase; Chizu Fukushima; Shigeru Kohno
Journal:  Am J Respir Crit Care Med       Date:  2003-12-04       Impact factor: 21.405

6.  Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.

Authors:  Arvin S Yang; Edmund C Lattime
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

7.  Role of serum neutralizing antibody in reinfection of respiratory syncytial virus.

Authors:  Yukihiko Kawasaki; Mitsuaki Hosoya; Masahiko Katayose; Hitoshi Suzuki
Journal:  Pediatr Int       Date:  2004-04       Impact factor: 1.524

8.  Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes.

Authors:  Jojanneke Heidema; Godelieve J de Bree; Patricia M A de Graaff; Wendy W C van Maren; Peter Hoogerhout; Theo A Out; Jan L L Kimpen; Grada M van Bleek
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

9.  Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection.

Authors:  Marc Beyer; Holger Bartz; Katharina Hörner; Sandra Doths; Cordula Koerner-Rettberg; Jürgen Schwarze
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

10.  The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific.

Authors:  Susan M Bueno; Pablo A González; Leandro J Carreño; Jaime A Tobar; Guido C Mora; Cristian J Pereda; Flavio Salazar-Onfray; Alexis M Kalergis
Journal:  Immunology       Date:  2008-02-08       Impact factor: 7.397

View more
  68 in total

1.  Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype.

Authors:  John J Erickson; Pengcheng Lu; Sherry Wen; Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; Yu Shyr; John V Williams
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

Review 2.  Therapeutic targeting of respiratory syncytial virus G-protein.

Authors:  Lawrence M Kauvar; Jennifer L Harcourt; Lia M Haynes; Ralph A Tripp
Journal:  Immunotherapy       Date:  2010-09       Impact factor: 4.196

3.  Impaired learning resulting from respiratory syncytial virus infection.

Authors:  Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Roberto S Gómez; Sebastián A Riquelme; Claudia M Cortés; Javier A Valenzuela; Rodrigo A Sandoval; Floria C Pancetti; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

4.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

5.  Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

Authors:  Susan M Bueno; Pablo A González; Kelly M Cautivo; Jorge E Mora; Eduardo D Leiva; Hugo E Tobar; Glenn J Fennelly; Eliseo A Eugenin; William R Jacobs; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 6.  Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.

Authors:  Janyra A Espinoza; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

Review 7.  Functional anatomy of T cell activation and synapse formation.

Authors:  David R Fooksman; Santosh Vardhana; Gaia Vasiliver-Shamis; Jan Liese; David A Blair; Janelle Waite; Catarina Sacristán; Gabriel D Victora; Alexandra Zanin-Zhorov; Michael L Dustin
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

Review 9.  Influence of dendritic cells on viral pathogenicity.

Authors:  Giulia Freer; Donatella Matteucci
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

Review 10.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.